Safety and efficacy of programmed cell death‐1 antibody SHR‐1210 combined with concurrent chemoradiotherapy to treat locally advanced esophageal squamous cell carcinoma: a study protocol for an exploratory single‐arm phase Ib trial

user-5f8cf9244c775ec6fa691c99(2020)

引用 0|浏览11
暂无评分
关键词
Oncology,Antibody,Medicine,Concurrent chemoradiotherapy,Esophageal squamous cell carcinoma,Internal medicine,Locally advanced,Programmed cell death 1
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要